A detailed history of Meriwether Wealth & Planning, LLC transactions in Amgen Inc stock. As of the latest transaction made, Meriwether Wealth & Planning, LLC holds 1,068 shares of AMGN stock, worth $364,946. This represents 0.2% of its overall portfolio holdings.

Number of Shares
1,068
Previous 1,141 6.4%
Holding current value
$364,946
Previous $322 Million 8.56%
% of portfolio
0.2%
Previous 0.19%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2025

Jan 14, 2026

SELL
$290.13 - $341.71 $21,179 - $24,944
-73 Reduced 6.4%
1,068 $350 Million
Q3 2025

Oct 14, 2025

SELL
$271.18 - $309.22 $37,965 - $43,290
-140 Reduced 10.93%
1,141 $322 Million
Q2 2025

Jul 11, 2025

SELL
$262.28 - $309.85 $95,469 - $112,785
-364 Reduced 22.13%
1,281 $358 Million
Q1 2025

Apr 21, 2025

BUY
$258.59 - $327.36 $11,377 - $14,403
44 Added 2.75%
1,645 $513 Million
Q4 2024

Feb 07, 2025

BUY
$258.78 - $328.31 $414,306 - $525,624
1,601 New
1,601 $417 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $183B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Meriwether Wealth & Planning, LLC Portfolio

Follow Meriwether Wealth & Planning, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Meriwether Wealth & Planning, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Meriwether Wealth & Planning, LLC with notifications on news.